1. Home
  2. IRWD vs AVK Comparison

IRWD vs AVK Comparison

Compare IRWD & AVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRWD
  • AVK
  • Stock Information
  • Founded
  • IRWD 1998
  • AVK 2003
  • Country
  • IRWD United States
  • AVK United States
  • Employees
  • IRWD N/A
  • AVK N/A
  • Industry
  • IRWD Biotechnology: Pharmaceutical Preparations
  • AVK Trusts Except Educational Religious and Charitable
  • Sector
  • IRWD Health Care
  • AVK Finance
  • Exchange
  • IRWD Nasdaq
  • AVK Nasdaq
  • Market Cap
  • IRWD 510.5M
  • AVK 434.9M
  • IPO Year
  • IRWD 2010
  • AVK N/A
  • Fundamental
  • Price
  • IRWD $3.53
  • AVK $12.14
  • Analyst Decision
  • IRWD Buy
  • AVK
  • Analyst Count
  • IRWD 4
  • AVK 0
  • Target Price
  • IRWD $12.00
  • AVK N/A
  • AVG Volume (30 Days)
  • IRWD 1.9M
  • AVK 112.9K
  • Earning Date
  • IRWD 02-13-2025
  • AVK 01-01-0001
  • Dividend Yield
  • IRWD N/A
  • AVK 11.85%
  • EPS Growth
  • IRWD N/A
  • AVK N/A
  • EPS
  • IRWD N/A
  • AVK N/A
  • Revenue
  • IRWD $378,418,000.00
  • AVK N/A
  • Revenue This Year
  • IRWD N/A
  • AVK N/A
  • Revenue Next Year
  • IRWD N/A
  • AVK N/A
  • P/E Ratio
  • IRWD N/A
  • AVK N/A
  • Revenue Growth
  • IRWD N/A
  • AVK N/A
  • 52 Week Low
  • IRWD $3.06
  • AVK $9.24
  • 52 Week High
  • IRWD $15.70
  • AVK $12.16
  • Technical
  • Relative Strength Index (RSI)
  • IRWD 44.66
  • AVK 52.79
  • Support Level
  • IRWD $3.39
  • AVK $12.03
  • Resistance Level
  • IRWD $4.05
  • AVK $12.39
  • Average True Range (ATR)
  • IRWD 0.30
  • AVK 0.12
  • MACD
  • IRWD 0.02
  • AVK -0.03
  • Stochastic Oscillator
  • IRWD 47.47
  • AVK 28.00

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

About AVK Advent Convertible and Income Fund

Advent Convertible & Income Fund is a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The Fund invests in various sectors, such as communications, utilities, energy, industrial, technology, and others.

Share on Social Networks: